Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study

Down, 1866, Observations on an ethnic classification of idiots. Clinical Lectures and Reports, London Hospital, 3, 259

Nicolaides, 1992, Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy, BMJ, 304, 867, 10.1136/bmj.304.6831.867

Snidjers, 1998, UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation, Lancet, 351, 343

Nicolaides, 1998, Correct estimation of parameters for ultrasound nuchal translucency screening, Prenat Diagn, 18, 519, 10.1002/(SICI)1097-0223(199805)18:5<519::AID-PD398>3.0.CO;2-U

Sandikcioglu, 1994, The prenatal development of the human nasal and vomeral bones, J Craniofac Genet Dev Biol, 14, 124

Moss, 1962, The functional matrix

von Kaisenberg, 1998, Collagen type VI gene expression in the skin of trisomy 21 fetuses, Obstet Gynecol, 91, 319, 10.1016/S0029-7844(97)00697-2

von Kaisenberg, 1998, Morphological classification of nuchal skin in fetuses with trisomy 21, 18 and 13 at 12–18 weeks and in a trisomy 16 mouse, Anat Embryol, 197, 105, 10.1007/s004290050123

Bohlandt, 2000, Hyaluronan in the nuchal skin of chromosomally abnormal fetuses, Hum Reprod, 15, 1155, 10.1093/humrep/15.5.1155

Cuckle, 1991, Birth prevalence of Down's syndrome in England and Wales, Prenat Diagn, 11, 29, 10.1002/pd.1970110106

Wald, 1992, Antenatal maternal serum screening for Down's syndrome: results of a demonstration project, BMJ, 305, 391, 10.1136/bmj.305.6850.391

Dick, 1996, Canadian Task Force on the Period Health Examination. Prenatal screening and diagnosis of Down's syndrome, Can Med Assoc J, 154, 465

Spencer, 1999, A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free (β-human chorionic gonadotropin and pregnancy-associated plasma protein-A, Ultrasound Obstet Gynecol, 13, 231, 10.1046/j.1469-0705.1999.13040231.x

de Graaf, 1999, Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency, Prenat Diagn, 19, 458, 10.1002/(SICI)1097-0223(199905)19:5<458::AID-PD569>3.0.CO;2-A

Cuckle, 2001, Integrating Down's syndrome screening, Curr Opin Obstet Gynaecol, 13, 175, 10.1097/00001703-200104000-00013